To receive semaglutide legally, you typically: Schedule a consultation with a healthcare provider Review your medical history and lab work Discuss goals (blood sugar control or weight management) Receive a prescription if appropriate Some telehealth platforms can also prescribe semaglutide after evaluation, depending on local regulations
The platform states that the clinical decision rests entirely with the evaluating clinician and that MEDVi cannot guarantee any individual will receive a prescription
Obesity is a common, costly disease that, as the CDC reports, affects some groups more than others, including Black adults and adults with less education

Sources: Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine Realworld use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database PMC Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity | Obesity | JAMA Internal Medicine | JAMA Network Semaglutide StatPearls NCBI Bookshelf Safety of Semaglutide PMC Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes PMC Realworld evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP1RAbased weightloss therapies PMC Liraglutide for weight management: a critical review of the evidence PMC Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus PMC Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network

FDA Approves Lillys Oral GLP-1 Orforglipron for Obesity